| Cash Flow | 2025-08-31 | 2025-02-28 | 2024-11-30 | 2024-08-31 |
|---|---|---|---|---|
| Net income | 727 | 3,008 | 2,214 | 1,051 |
| Depreciation | - | 576 | 378 | 188 |
| Depreciation and amortization | 190 | - | - | - |
| Deferred income taxes | -25 | -304 | -188 | -53 |
| Stock-based compensation | 185 | 544 | 375 | 183 |
| Amortization, impairment and other | - | 35 | -9 | -4 |
| Impairment and other | 8 | - | - | - |
| Net foreign currency adjustments | -34 | -24 | -54 | 7 |
| (increase) decrease in accounts receivable | 215 | 164 | 943 | 312 |
| (increase) decrease in inventories | 610 | 99 | 547 | 679 |
| (increase) decrease in prepaid expenses, operating lease right-of-use assets and other current and non-current assets | 165 | 235 | -140 | 265 |
| Increase (decrease) in accounts payable, accrued liabilities, operating lease liabilities and other current and non-current liabilities | 93 | -150 | -31 | 292 |
| Cash provided (used) by operations | 222 | 3,235 | 1,443 | 394 |
| Purchases of short-term investments | 355 | 2,664 | 2,084 | 968 |
| Maturities of short-term investments | 209 | 258 | 197 | 144 |
| Sales of short-term investments | 294 | 2,439 | 1,886 | 778 |
| Additions to property, plant and equipment | 207 | 330 | 249 | 120 |
| Other investing activities | - | -8 | -10 | 0 |
| Cash provided (used) by investing activities | -59 | -289 | -240 | -166 |
| Increase (decrease) in notes payable, net | -1 | -2 | 43 | 6 |
| Proceeds from exercise of stock options and other stock issuances | 127 | 400 | 345 | 131 |
| Repurchase of common stock | 126 | 2,786 | 2,280 | 1,184 |
| Dividends common and preferred | 591 | 1,709 | 1,115 | 558 |
| Other financing activities | -7 | -79 | -63 | -17 |
| Cash provided (used) by financing activities | -598 | -4,176 | -3,070 | -1,622 |
| Effect of exchange rate changes on cash and equivalents | -5 | -29 | -14 | 19 |
| Net increase (decrease) in cash and equivalents | -440 | -1,259 | -1,881 | -1,375 |
| Cash and cash equivalents at beginning of period | 7,464 | 9,860 | 9,860 | 9,860 |
| Cash and cash equivalents at end of period | 7,024 | 8,601 | 7,979 | 8,485 |
NIKE, Inc. (NKE)
NIKE, Inc. (NKE)